Literature DB >> 32029519

Multifocal circumscribed choroidal hemangioma: a rare occurrence.

Vijitha S Vempuluru1, Swathi Kaliki.   

Abstract

A 32-year-old Asian-Indian woman presented with painless diminution of vision in her left eye (oculus sinister (OS)) and fundus examination OS revealed a large dome-shaped orangish-red subretinal lesion at the macula along with a smaller lesion on the superotemporal arcade. Indocyanine green angiography and optical coherence tomography features confirmed the diagnosis of multifocal circumscribed choroidal hemangioma (CCH). There was no evidence of Sturge-Weber syndrome. CCH is usually solitary with only one reported case of multifocal CCH in the literature. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  hemangioma; macula; retina

Mesh:

Substances:

Year:  2020        PMID: 32029519      PMCID: PMC7035807          DOI: 10.1136/bcr-2019-233222

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Bilateral circumscribed haemangioma of the choroid not associated with systemic vascular syndrome.

Authors:  P Perri; C Incorvaia; C Costagliola; F Parmeggiani; G Lamberti; B Paduano; A Sebastiani; P Paolo; I Carlo; C Ciro; P Francesco; P Beatrice; S Adolfo
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  Bilateral circumscribed choroidal hemangioma in an otherwise healthy individual.

Authors:  Hoai Viet Tran; Ann Schalenbourg; Leonidas Zografos
Journal:  Retin Cases Brief Rep       Date:  2007

3.  Intraocular tumors. I. Bilateral hemangioma of the choroid.

Authors:  C L SCHEPENS; A SCHWARTZ
Journal:  AMA Arch Ophthalmol       Date:  1958-07

Review 4.  Circumscribed Choroidal Hemangioma.

Authors:  Saeed Karimi; Ramin Nourinia; Arman Mashayekhi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

5.  Circumscribed choroidal haemangioma: clinical and topographical features.

Authors:  Jørgen Krohn; Pukhraj Rishi; Torbjørn Frøystein; Arun D Singh
Journal:  Br J Ophthalmol       Date:  2019-01-02       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.